Nippon Chemiphar Co., Ltd.

Everything filed on one company: the documents, the statements, the register, the board, the buyback and the property table — each figure as filed, with the report it came from.

Latest values as text and table

Nippon Chemiphar Co., Ltd.

Nippon Chemiphar Co., Ltd. (日本ケミファ株式会社, 4539), Pharmaceutical. 12 cross-shareholdings, a board of 10 and 10 largest shareholders, as filed on EDINET for the year to March 2026. EDINET filing S100YBOB, filed 2026-06-15. Source: company filings on EDINET (Financial Services Agency of Japan).

Financial summary

Five-year summary as filed, latest filing per fiscal year
Fiscal year endRevenue (¥bn)Profit (¥bn)Total assets (¥bn)EPS (¥)DPS (¥)Employees
2022-03-3132.50.749.5194.3350.00809
2023-03-3131.60.348.694.0750.00872
2024-03-3130.7−0.249.5−50.1450.00887
2025-03-3132.60.349.981.7250.00855
2026-03-3133.10.250.054.8150.00878

Source: company filings on EDINET (Financial Services Agency of Japan). · JSON

Cross-shareholdings

Ten largest cross-shareholdings by book value, latest annual report
Company heldSharesBook value (¥bn)% of shares outstanding
Tokyo Kiraboshi Financial Group, Inc.60,8920.70.2
ZERIA PHARMACEUTICAL CO., LTD.172,7000.40.4
Alfresa Holdings Corporation58,0000.10.0
Mizuho Financial Group, Inc.23,1000.10.0
Hokuhoku Financial Group, Inc.15,1000.10.0
Delta-Fly Pharma㈱430,3000.1—
SUSMED,Inc.58,8000.10.3
Astena Holdings Co., Ltd.100,0000.00.2
TOHO HOLDINGS CO.,LTD.7,8900.00.0
HOKUYAKU TAKEYAMA Holdings,Inc.36,0020.00.2

% of shares outstanding: shares held ÷ (issuer's issued shares − treasury shares) × 100, both as filed, the denominator taken from the issuer's own annual securities report nearest the holding's fiscal year end

Source: company filings on EDINET (Financial Services Agency of Japan). · JSON · Markdown